{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:28Z","timestamp":1791910648439,"version":"4.3.4"},"reference-count":212,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"Ministry of Science and ICT (MSIT), Korea","doi-asserted-by":"publisher","award":["2020R1A4A4079722"],"award-info":[{"award-number":["2020R1A4A4079722"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Ministry of Science and ICT (MSIT), Korea","doi-asserted-by":"publisher","award":["2020M3E5D9080661"],"award-info":[{"award-number":["2020M3E5D9080661"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Ministry of Science and ICT (MSIT), Korea","doi-asserted-by":"publisher","award":["2020R1C1C1008366"],"award-info":[{"award-number":["2020R1C1C1008366"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cancer cells because cancer cells have unique characteristics such as a high negative charge and abundance of microvilli in the cell membrane when compared to a normal cell. ACPs have several advantages, such as high specificity, cost-effectiveness, low immunogenicity, minimal toxicity, and high tolerance under normal physiological conditions. However, the development and identification of ACPs are time-consuming and expensive in traditional wet-lab-based approaches. Thus, the application of artificial intelligence on the approaches can save time and reduce the cost to identify candidate ACPs. Recently, machine learning (ML), deep learning (DL), and hybrid learning (ML combined DL) have emerged into the development of ACPs without experimental analysis, owing to advances in computer power and big data from the power system. Additionally, we suggest that combination therapy with classical approaches and ACPs might be one of the impactful approaches to increase the efficiency of cancer therapy.<\/jats:p>","DOI":"10.3390\/pharmaceutics14050997","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T21:31:20Z","timestamp":1652045480000},"page":"997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics"],"prefix":"10.3390","volume":"14","author":[{"given":"Ji Su","family":"Hwang","sequence":"first","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5914-2471","authenticated-orcid":false,"given":"Seok Gi","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-4556","authenticated-orcid":false,"given":"Tae Hwan","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Physiology, Ajou University School of Medicine, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-7455","authenticated-orcid":false,"given":"Yong Eun","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyeon","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Physiology, Ajou University School of Medicine, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-9478","authenticated-orcid":false,"given":"Gwang","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, 206 World Cup-ro, Suwon 16499, Korea"},{"name":"Department of Physiology, Ajou University School of Medicine, 206 World Cup-ro, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a Preventable Disease that Requires Major Lifestyle Changes","volume":"25","author":"Anand","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"213676","DOI":"10.1016\/j.ccr.2020.213676","article-title":"Diversified strategies based on nanoscale metal-organic frameworks for cancer therapy: The leap from monofunctional to versatile","volume":"431","author":"Ren","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance: A Brief Review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_6","first-page":"381","article-title":"Managing the adverse effects of radiation therapy","volume":"82","author":"Berkey","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pmr.2016.08.003","article-title":"Clinical Evaluation and Management of Radiation Fibrosis Syndrome","volume":"28","author":"Stubblefield","year":"2017","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3857\/roj.2020.00213","article-title":"Late side effects of radiation treatment for head and neck cancer","volume":"38","author":"Brook","year":"2020","journal-title":"Radiat. Oncol. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110639","DOI":"10.1016\/j.biopha.2020.110639","article-title":"How to overcome the side effects of tumor immunotherapy","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_10","first-page":"141","article-title":"Pancreatic Extracts in the Treatment of Diabetes Mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can. Med. Assoc. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0021-9258(18)49238-1","article-title":"The sequence of amino acids in oxytocin, with a proposal for the structure of Oxytocin","volume":"205","author":"Ressler","year":"1953","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: Current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1039\/C6CS00176A","article-title":"Peptide self-assembly: Thermodynamics and kinetics","volume":"45","author":"Wang","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The Current State of Peptide Drug Discovery: Back to the Future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/med.20252","article-title":"On the selectivity and efficacy of defense peptides with respect to cancer cells","volume":"33","author":"Harris","year":"2013","journal-title":"Med. Res. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: Historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorganic. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Trinidad-Calder\u00f3n, P.A., Varela-Chinchilla, C.D., and Garc\u00eda-Lara, S. (2021). Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics. Molecules, 26.","DOI":"10.3390\/molecules26247453"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liscano, Y., O\u00f1ate-Garz\u00f3n, J., and Delgado, J.P. (2020). Peptides with Dual Antimicrobial\u2013Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides. Molecules, 25.","DOI":"10.3390\/molecules25184245"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/med.21658","article-title":"Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening","volume":"40","author":"Basith","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.2174\/092986712801661004","article-title":"The Use of Therapeutic Peptides to Target and to Kill Cancer Cells","volume":"19","author":"Boohaker","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fchem.2020.00571","article-title":"Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77121","DOI":"10.18632\/oncotarget.20365","article-title":"MLACP: Machine-learning-based prediction of anticancer peptides","volume":"8","author":"Manavalan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"bbab008","DOI":"10.1093\/bib\/bbab008","article-title":"Anticancer peptides prediction with deep representation learning features","volume":"22","author":"Lv","year":"2021","journal-title":"Briefings Bioinform."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110009","DOI":"10.1016\/j.biopha.2020.110009","article-title":"Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine","volume":"125","author":"Bashraheel","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","unstructured":"Koutsopoulos, S. (2018). 1-Peptide synthesis: Methods, trends, and challenges. Peptide Applications in Biomedicine, Biotechnology and Bioengineering, Woodhead Publishing."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide Vaccine: Progress and Challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fnins.2017.00183","article-title":"Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo","volume":"11","author":"Verbeke","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.csbj.2018.10.007","article-title":"iGHBP: Computational identification of growth hormone binding proteins from sequences using extremely randomised tree","volume":"16","author":"Basith","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2018.00276","article-title":"AIPpred: Sequence-Based Prediction of Anti-inflammatory Peptides Using Random Forest","volume":"9","author":"Manavalan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tesauro, D., Accardo, A., Diaferia, C., Milano, V., Guillon, J., Ronga, L., and Rossi, F. (2019). Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives. Molecules, 24.","DOI":"10.3390\/molecules24020351"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-Penetrating Peptides: From Basic Research to Clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5761517","DOI":"10.1155\/2017\/5761517","article-title":"PSBinder: A Web Service for Predicting Polystyrene Surface-Binding Peptides","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3389\/fimmu.2018.01695","article-title":"iBCE-EL: A New Ensemble Learning Framework for Improved Linear B-Cell Epitope Prediction","volume":"9","author":"Manavalan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1039\/C8MD00370J","article-title":"Lipophilicity prediction of peptides and peptide derivatives by consensus machine learning","volume":"9","author":"Fuchs","year":"2018","journal-title":"MedChemComm"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"De la Torre, B.G., and Albericio, F. (2020). Peptide Therapeutics 2.0. Molecules, 25.","DOI":"10.3390\/molecules25102293"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpba.2014.06.012","article-title":"Related impurities in peptide medicines","volume":"101","author":"Bracke","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lee, A.C.-L., Harris, J.L., Khanna, K.K., and Hong, J.-H. (2019). A Comprehensive Review on Current Advances in Peptide Drug Development and Design. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102383"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nbt.1524","article-title":"Prediction of high-responding peptides for targeted protein assays by mass spectrometry","volume":"27","author":"Fusaro","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/bioinformatics\/btq112","article-title":"A machine learning approach to predicting protein\u2013ligand binding affinity with applications to molecular docking","volume":"26","author":"Ballester","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3389\/fimmu.2018.01783","article-title":"PIP-EL: A New Ensemble Learning Method for Improved Proinflammatory Peptide Predictions","volume":"9","author":"Manavalan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1038\/s41467-018-07717-6","article-title":"Discovering de novo peptide substrates for enzymes using machine learning","volume":"9","author":"Tallorin","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","article-title":"ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation","volume":"17","author":"Yi","year":"2019","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"bbaa153","DOI":"10.1093\/bib\/bbaa153","article-title":"AntiCP 2.0: An updated model for predicting anticancer peptides","volume":"22","author":"Agrawal","year":"2020","journal-title":"Briefings Bioinform."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"srep02984","DOI":"10.1038\/srep02984","article-title":"In Silico Models for Designing and Discovering Novel Anticancer Peptides","volume":"3","author":"Tyagi","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jtbi.2013.08.037","article-title":"Predicting anticancer peptides with Chou\u2032s pseudo amino acid composition and investigating their mutagenicity via Ames test","volume":"341","author":"Hajisharifi","year":"2014","journal-title":"J. Theor. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10989-014-9435-7","article-title":"ACPP: A web server for prediction and design of anti-cancer peptides","volume":"21","author":"Vijayakumar","year":"2015","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.18632\/oncotarget.7815","article-title":"iACP: A sequence-based tool for identifying anticancer peptides","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.artmed.2017.06.008","article-title":"iACP-GAEnsC: Evolutionary genetic algorithm based ensemble classification of anticancer peptides by utilizing hybrid feature space","volume":"79","author":"Akbar","year":"2017","journal-title":"Artif. Intell. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xu, L., Liang, G., Wang, L., and Liao, C. (2018). A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides. Genes, 9.","DOI":"10.3390\/genes9030158"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1093\/bioinformatics\/bty451","article-title":"ACPred-FL: A sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides","volume":"34","author":"Wei","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Boopathi, V., Subramaniyam, S., Malik, A., Lee, G., Manavalan, B., and Yang, D.-C. (2019). mACPpred: A Support Vector Machine-Based Meta-Predictor for Identification of Anticancer Peptides. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081964"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Schaduangrat, N., Nantasenamat, C., Prachayasittikul, V., and Shoombuatong, W. (2019). ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides. Molecules, 24.","DOI":"10.3390\/molecules24101973"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1093\/bioinformatics\/btz246","article-title":"PEPred-Suite: Improved and robust prediction of therapeutic peptides using adaptive feature representation learning","volume":"35","author":"Wei","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhao, T., Hu, Y., and Zang, T. (2020). DRACP: A novel method for identification of anticancer peptides. BMC Bioinform., 21.","DOI":"10.1186\/s12859-020-03812-y"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine Learning in Medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"ref_59","first-page":"143","article-title":"Big Data and Statistics: A Statistician\u2019s Perspective","volume":"5","author":"Rossell","year":"2015","journal-title":"Metode Sci. Stud. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1609893113","article-title":"Mapping membrane activity in undiscovered peptide sequence space using machine learning","volume":"113","author":"Lee","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acs.jproteome.8b00148","article-title":"Machine-Learning-Based Prediction of Cell-Penetrating Peptides and Their Uptake Efficiency with Improved Accuracy","volume":"17","author":"Manavalan","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wu, C., Gao, R., Zhang, Y., and De Marinis, Y. (2019). PTPD: Predicting therapeutic peptides by deep learning and word2vec. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-3006-z"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.omtn.2020.10.005","article-title":"DeepACP: A Novel Computational Approach for Accurate Identification of Anticancer Peptides by Deep Learning Algorithm","volume":"22","author":"Yu","year":"2020","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1093\/bioinformatics\/btab560","article-title":"Learning embedding features based on multisense-scaled attention architecture to improve the predictive performance of anticancer peptides","volume":"37","author":"He","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"698477","DOI":"10.3389\/fgene.2021.698477","article-title":"ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"200004","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: Classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fimmu.2017.01320","article-title":"Antimicrobial Peptides as Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview","volume":"8","author":"Roudi","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2174\/1871520614666140825110001","article-title":"HLA-I antigen presentation and tapasin influence immune responses against malignant brain tumors\u2014Considerations for successful immunotherapy","volume":"14","author":"Darabi","year":"2014","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1391972","DOI":"10.1080\/2162402X.2017.1391972","article-title":"Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma","volume":"7","author":"Dutoit","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.7b08148","article-title":"Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel","volume":"12","author":"Jin","year":"2018","journal-title":"ACS Nano"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40290-018-0261-7","article-title":"Peptide-Based Therapeutics for Oncology","volume":"33","author":"Fisher","year":"2019","journal-title":"Pharm. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.copbio.2006.10.002","article-title":"Therapeutic peptides: Technological advances driving peptides into development","volume":"17","author":"Sato","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Tornesello, A.L., Borrelli, A., Buonaguro, L., Buonaguro, F.M., and Tornesello, M.L. (2020). Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities. Molecules, 25.","DOI":"10.3390\/molecules25122850"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","article-title":"The Role of Cathelicidin LL-37 in Cancer Development","volume":"64","author":"Piktel","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.25489","article-title":"Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications","volume":"127","author":"Wu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jprot.2009.01.002","article-title":"Human defensins as cancer biomarkers and antitumour molecules","volume":"72","author":"Droin","year":"2009","journal-title":"J. Proteom."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.18632\/oncotarget.6520","article-title":"Human \u03b2-defensin 3 contains an oncolytic motif that binds PI (4, 5) P2 to mediate tumour cell permeabilisation","volume":"7","author":"Phan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_79","first-page":"5","article-title":"Peptides with Dual Antimicrobial and Anticancer Activities","volume":"5","author":"Silva","year":"2017","journal-title":"Front. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/psc.1434","article-title":"Synthesis of anticancer heptapeptides containing a unique lipophilic \u03b22, 2-amino acid building block","volume":"18","author":"Ausbacher","year":"2012","journal-title":"J. Pept. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biocel.2018.05.013","article-title":"MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells","volume":"101","author":"Ke","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/bmc-2015-0035","article-title":"Inspiration from the mirror: D-amino acid containing peptides in biomedical approaches","volume":"7","author":"Feng","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1021\/bm5010355","article-title":"d-Amino Acids Modulate the Cellular Response of Enzymatic-Instructed Supramolecular Nanofibers of Small Peptides","volume":"15","author":"Shi","year":"2014","journal-title":"Biomacromolecules"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Bastings, J.J.A.J., Van Eijk, H.M., Olde Damink, S.W., and Rensen, S.S. (2019). d-amino Acids in Health and Disease: A Focus on Cancer. Nutrients, 11.","DOI":"10.3390\/nu11092205"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yexmp.2015.08.021","article-title":"Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03","volume":"99","author":"Hilchie","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Maxian, T., Gerlitz, L., Riedl, S., Rinner, B., and Zweytick, D. (2021). Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168469"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00005-014-0268-z","article-title":"D-K6L9 Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice","volume":"62","author":"Smolarczyk","year":"2014","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1158\/0008-5472.CAN-05-4569","article-title":"Inhibition of Tumor Growth and Elimination of Multiple Metastases in Human Prostate and Breast Xenografts by Systemic Inoculation of a Host Defense\u2013Like Lytic Peptide","volume":"66","author":"Papo","year":"2006","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jmb.2010.03.005","article-title":"Systematic mutational analysis of peptide inhibition of the p53\u2013MDM2\/MDMX interactions","volume":"398","author":"Li","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.bmcl.2017.09.014","article-title":"d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2\/MDMX interactions","volume":"27","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-022-00332-w","article-title":"Anti-cancer peptide-based therapeutic strategies in solid tumors","volume":"27","author":"Fath","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1114518108","article-title":"Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma","volume":"108","author":"Agemy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fonc.2013.00216","article-title":"Tumor-Penetrating Peptides","volume":"3","author":"Teesalu","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9367845","DOI":"10.1155\/2019\/9367845","article-title":"iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers","volume":"2019","author":"Zuo","year":"2019","journal-title":"J. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: A database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: The antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"D1119","DOI":"10.1093\/nar\/gkv1114","article-title":"SATPdb: A database of structurally annotated therapeutic peptides","volume":"44","author":"Singh","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1038\/s41598-021-93124-9","article-title":"Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties","volume":"11","author":"Huang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2009.08.043","article-title":"Cationic amphiphilic peptides with cancer-selective toxicity","volume":"625","author":"Schweizer","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.bbamem.2016.06.025","article-title":"Biophysics in cancer: The relevance of drug-membrane interaction studies","volume":"1858","author":"Alves","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Casini","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Lee, S.-H., and Griffiths, J.R. (2020). How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH. Cancers, 12.","DOI":"10.3390\/cancers12061616"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","article-title":"From antimicrobial to anticancer peptides. A review","volume":"4","author":"Gaspar","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/cbdd.13023","article-title":"Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities","volume":"90","author":"Zhang","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2014.05.002","article-title":"Peptide-based cancer therapy: Opportunity and challenge","volume":"351","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/CMAR.S232708","article-title":"Research Progress Evaluating the Function and Mechanism of Anti-Tumor Peptides","volume":"12","author":"Pan","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1158\/0008-5472.CAN-16-0302","article-title":"A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death","volume":"76","author":"Kotula","year":"2016","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/or.2017.5778","article-title":"Anticancer potential of bioactive peptides from animal sources (Review)","volume":"38","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-981-13-3588-4_9","article-title":"Anticancer Activities of Natural and Synthetic Peptides","volume":"1117","author":"Hilchie","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez, N.D.J.H., Casanova, Y.V., Chimbi, A.K.G., Hern\u00e1ndez, E., Castro, A.L.L., Diaz, J.M.M., Monroy, Z.J.R., and Casta\u00f1eda, J.E.G. (2017). Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. Molecules, 22.","DOI":"10.3390\/molecules22030452"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1158\/1078-0432.CCR-06-2008","article-title":"Oral Lactoferrin Results in T Cell\u2013Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma In vivo","volume":"13","author":"Wolf","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.intimp.2013.10.014","article-title":"Anti-tumor activity of a peptide combining patterns of insect alloferons and mammalian immunoglobulins in na\u00efve and tumor antigen vaccinated mice","volume":"17","author":"Chernysh","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fphar.2020.00733","article-title":"Discovering Anti-Cancer Drugs via Computational Methods","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing Drug Discovery via Artificial Intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.trci.2017.10.005","article-title":"Drug discovery and development: Role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nascimento, A.C.A., Prud\u00eancio, R.B.C., and Costa, I.G. (2016). A multiple kernel learning algorithm for drug-target interaction prediction. BMC Bioinform., 17.","DOI":"10.1186\/s12859-016-0890-3"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1021\/ci030298n","article-title":"ESP: A Method to Predict Toxicity and Pharmacological Properties of Chemicals Using Multiple MCASE Databases","volume":"44","author":"Klopman","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Menden, M.P., Iorio, F., Garnett, M., McDermott, U., Benes, C.H., Ballester, P.J., and Saez-Rodriguez, J. (2013). Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061318"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: Present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Liu, L., and \u00d6zsu, M.T. (2009). Cross-Validation. Encyclopedia of Database Systems, Springer.","DOI":"10.1007\/978-0-387-39940-9"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Deisy, C., Subbulakshmi, B., Baskar, S., and Ramaraj, N. (2007, January 13\u201315). Efficient dimensionality reduction approaches for feature selection. Proceedings of the International Conference on Computational Intelligence and Multimedia Applications (ICCIMA 2007), Sivakasi, India.","DOI":"10.1109\/ICCIMA.2007.288"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4304\/jsw.5.12.1371-1377","article-title":"Feature Selection via Correlation Coefficient Clustering","volume":"5","author":"Hsu","year":"2010","journal-title":"J. Softw."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","article-title":"Permutation importance: A corrected feature importance measure","volume":"26","author":"Altmann","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1109\/TIM.2004.834070","article-title":"PCA-Based Feature Selection Scheme for Machine Defect Classification","volume":"53","author":"Malhi","year":"2004","journal-title":"IEEE Trans. Instrum. Meas."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nbt1206-1565","article-title":"What is a support vector machine?","volume":"24","author":"Noble","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1109\/TSMC.1985.6313426","article-title":"A fuzzy K-nearest neighbor algorithm","volume":"SMC-15","author":"Keller","year":"1985","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/01431160412331269698","article-title":"Random forest classifier for remote sensing classification","volume":"26","author":"Pal","year":"2005","journal-title":"Int. J. Remote Sens."},{"key":"ref_136","unstructured":"Lakshminarayanan, B., Pritzel, A., and Blundell, C. (2017, January 4\u20139). Simple and scalable predictive uncertainty estimation using deep ensembles. Proceedings of the 31st Conference on Neural Information Processing Systems, Long Beach, CA, USA."},{"key":"ref_137","unstructured":"Ke, G., Meng, Q., Finley, T., Wang, T., Chen, W., Ma, W., Ye, Q., and Liu, T.-Y. (2017, January 4\u20139). LightGBM: A highly efficient gradient boosting decision tree. Proceedings of the 31st International Conference on Neural Information Processing Systems, Long Beach, CA, USA."},{"key":"ref_138","first-page":"84","article-title":"Imagenet classification with deep convolutional neural networks","volume":"60","author":"Krizhevsky","year":"2017","journal-title":"NIPS"},{"key":"ref_139","unstructured":"Sutskever, I., Martens, J., and Hinton, G. (July, January 28). Generating Text with recurrent neural networks. Proceedings of the 28th International Conference on Machine Learning (ICML-11), Bellevue, WA, USA."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e00938","DOI":"10.1016\/j.heliyon.2018.e00938","article-title":"State-of-the-art in artificial neural network applications: A survey","volume":"4","author":"Abiodun","year":"2018","journal-title":"Heliyon"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.1705691114","article-title":"De novo peptide sequencing by deep learning","volume":"114","author":"Tran","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_142","unstructured":"Vaswani, A., Shazeer, N., Parmar, N., Uszkoreit, J., Jones, L., Gomez, A.N., Kaiser, \u0141., and Polosukhin, I. (2017, January 4\u20139). Attention is all you need. Proceedings of the 31st Conference on Neural Information Processing Systems (NIPS 2017), Long Beach, CA, USA."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Roopak, M., Tian, G.Y., and Chambers, J. (2019, January 7\u20139). Deep learning models for cyber security in IoT networks. Proceedings of the 2019 IEEE 9th Annual Computing and Communication Workshop and Conference (CCWC), Nevada, TX, USA.","DOI":"10.1109\/CCWC.2019.8666588"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1214\/12-AOAS595","article-title":"Dynamical functional prediction and classification, with application to traffic flow prediction","volume":"6","author":"Chiou","year":"2012","journal-title":"Ann. Appl. Stat."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1214\/09-SS054","article-title":"A survey of cross-validation procedures for model selection","volume":"4","author":"Arlot","year":"2010","journal-title":"Stat. Surv."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bib\/bbr001","article-title":"Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data","volume":"12","author":"Simon","year":"2011","journal-title":"Brief. Bioinform."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1002\/anie.201504018","article-title":"Multidimensional Design of Anticancer Peptides","volume":"54","author":"Lin","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/cmdc.201800204","article-title":"Designing Anticancer Peptides by Constructive Machine Learning","volume":"13","author":"Grisoni","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00894-019-4007-6","article-title":"De novo design of anticancer peptides by ensemble artificial neural networks","volume":"25","author":"Grisoni","year":"2019","journal-title":"J. Mol. Model."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Wang, S., Fei, W., Feng, Y., Shen, L., Yang, X., Wang, M., and Wu, M. (2021). Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115630"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: Immune epitope database\u2014analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"bas015","DOI":"10.1093\/database\/bas015","article-title":"CPPsite: A curated database of cell penetrating peptides","volume":"2012","author":"Gautam","year":"2012","journal-title":"Database"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkv1266","article-title":"CPPsite 2.0: A repository of experimentally validated cell-penetrating peptides","volume":"44","author":"Agrawal","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gku1141","article-title":"AHTPDB: A comprehensive platform for analysis and presentation of antihypertensive peptides","volume":"43","author":"Kumar","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/bioinformatics\/bty1047","article-title":"mAHTPred: A sequence-based meta-predictor for improving the prediction of anti-hypertensive peptides using effective feature representation","volume":"35","author":"Manavalan","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jaoac\/91.4.965","article-title":"BIOPEP Database and Other Programs for Processing Bioactive Peptide Sequences","volume":"91","author":"Minkiewicz","year":"2008","journal-title":"J. AOAC Int."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/bioinformatics\/btaa160","article-title":"HLPpred-Fuse: Improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation","volume":"36","author":"Hasan","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tcb.2013.08.003","article-title":"Mitochondria: Gatekeepers of response to chemotherapy","volume":"23","author":"Sarosiek","year":"2013","journal-title":"Trends Cell Biol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","article-title":"Thymoma: A Focus on Current Therapeutic Management","volume":"4","author":"Girard","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Pearce, A., Haas, M., Viney, R., Pearson, S.-A., Haywood, P., Brown, C., and Ward, R. (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184360"},{"key":"ref_164","first-page":"170","article-title":"Stem cells: Past, present, and future","volume":"5","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Petrelli, F., Zaniboni, A., Coinu, A., Cabiddu, M., Ghilardi, M., Sgroi, G., and Barni, S. (2013). Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083022"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-3701-4-7","article-title":"Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer","volume":"4","author":"Su","year":"2014","journal-title":"Cell Biosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fonc.2020.00429","article-title":"Physiological Role of Glutamate Dehydrogenase in Cancer Cells","volume":"10","author":"Saavedra","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s13277-015-3719-1","article-title":"Mitochondrial targeted peptides for cancer therapy","volume":"36","author":"Farsinejad","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer Cell Metabolism: Warburg and Beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Chen, X., Chen, S., and Yu, D. (2020). Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance. Metabolites, 10.","DOI":"10.3390\/metabo10070289"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.trecan.2021.02.004","article-title":"Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids","volume":"7","author":"Pranzini","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: A new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ccr.2010.08.017","article-title":"Cancer Metabolism: Is Glutamine Sweeter than Glucose?","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/onc.2012.635","article-title":"Control of glutamine metabolism by the tumor suppressor Rb","volume":"33","author":"Reynolds","year":"2014","journal-title":"Oncogene"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2012.09.017","article-title":"HIF2\u03b1 Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5","volume":"48","author":"Elorza","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-12-2334","article-title":"SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival","volume":"19","author":"Hassanein","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ijc.29535","article-title":"Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer","volume":"137","author":"Hassanein","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ijc.28749","article-title":"Targeting glutamine transport to suppress melanoma cell growth","volume":"135","author":"Wang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/BJ20070039","article-title":"Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)","volume":"406","author":"Robinson","year":"2007","journal-title":"Biochem. J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cell.2013.04.023","article-title":"TThe mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4","volume":"153","author":"Csibi","year":"2013","journal-title":"Cell"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","article-title":"Glutamate Dehydrogenase 1 Signals through Antioxidant Glutathione Peroxidase 1 to Regulate Redox Homeostasis and Tumor Growth","volume":"27","author":"Jin","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/1078-0432.CCR-14-1200","article-title":"Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate","volume":"21","author":"Korangath","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/bcr2154","article-title":"Targeting aspartate aminotransferase in breast cancer","volume":"10","author":"Thornburg","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: Pros, cons and beyond","volume":"124","author":"Tan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Kooshkaki, O., Derakhshani, A., Hosseinkhani, N., Torabi, M., Safaei, S., Brunetti, O., Racanelli, V., Silvestris, N., and Baradaran, B. (2020). Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124427"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3322\/caac.21596","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2008.124","article-title":"Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer","volume":"20","author":"Chuang","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e7765","DOI":"10.1136\/bmj.e7765","article-title":"Advances in radiotherapy","volume":"345","author":"Ahmad","year":"2012","journal-title":"BMJ"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.2011.1139","article-title":"Use of radioactive iodine for thyroid cancer","volume":"306","author":"Haymart","year":"2011","journal-title":"JAMA"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1962592","DOI":"10.1080\/2162402X.2021.1962592","article-title":"LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells","volume":"10","author":"Yamazaki","year":"2021","journal-title":"Oncoimmunology"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4155\/fmc-2017-0088","article-title":"LTX-315: A first-in-class oncolytic peptide that reprograms the tumor microenvironment","volume":"9","author":"Camilio","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_198","first-page":"161","article-title":"Hyperthermia: Role and Risk Factor for Cancer Treatment","volume":"10","author":"Jha","year":"2016","journal-title":"Achiev. Life Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/erd.10.13","article-title":"Current devices for high-performance whole-body hyperthermia therapy","volume":"7","author":"Jia","year":"2010","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fphar.2018.00831","article-title":"Biologically Targeted Magnetic Hyperthermia: Potential and Limitations","volume":"9","author":"Chang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10989-012-9295-y","article-title":"Anticancer Activity of Proapoptotic Peptides is Highly Improved by Thermal Targeting using Elastin-like Polypeptides","volume":"18","author":"Moktan","year":"2012","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.ju.0000106190.32540.6c","article-title":"Alternative Antiandrogens to Treat Prostate Cancer Relapse After Initial Hormone Therapy","volume":"171","author":"Kojima","year":"2004","journal-title":"J. Urol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/djs014","article-title":"Changing Concepts: Menopausal Hormone Therapy and Breast Cancer","volume":"104","author":"Chlebowski","year":"2012","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2165\/10484080-000000000-00000","article-title":"Degarelix","volume":"69","author":"Frampton","year":"2009","journal-title":"Drugs"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"vii107","DOI":"10.1093\/annonc\/mdq281","article-title":"Benefits and adverse effects of endocrine therapy","volume":"21","author":"Colleoni","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"McClements, L., Annett, S., Yakkundi, A., O\u2019Rourke, M., Valentine, A., Moustafa, N., Alqudah, A., Sim\u00f5es, B.M., Furlong, F., and Short, A. (2019). FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5500-0"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40824-018-0140-z","article-title":"Clinical development of photodynamic agents and therapeutic applications","volume":"22","author":"Baskaran","year":"2018","journal-title":"Biomater. Res."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Calixto, G.M.F., Bernegossi, J., De Freitas, L.M., Fontana, C.R., Chorilli, M., and Grumezescu, A.M. (2016). Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules, 21.","DOI":"10.3390\/molecules21030342"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/12469","article-title":"Anti-cancer activity of targeted pro-apoptotic peptides","volume":"5","author":"Ellerby","year":"1999","journal-title":"Nat. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/adfm.201500590","article-title":"Dual-Stage-Light-Guided Tumor Inhibition by Mitochondria-Targeted Photodynamic Therapy","volume":"25","author":"Han","year":"2015","journal-title":"Adv. Funct. Mater."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/997\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:06:48Z","timestamp":1760137608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":212,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["pharmaceutics14050997"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14050997","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]}}}